Do we need to screen every patient in intensive care unit for diabetes in community with high prevalence of diabetes?
Do we need to screen every patient in intensive care unit for diabetes in community with high prevalence of diabetes?作者机构：Department of Neurology Research Mayo Clinic Rochester MN 55902 United States Department of Anesthesiology and Peri-operative Medicine Critical Care IMP Mayo Clinic Rochester MN 55902 United States Health Science Center Texas A and M University Corpus Christi TX 78404 United States
出 版 物：《World Journal of Diabetes》 (世界糖尿病杂志（英文版）（电子版）)
年 卷 期：2019年第10卷第3期
页 面：137-139页
核心收录：
主 题：Diabetes mellitus Intensive care unit Microvascular Macrovascular Diabetes screening
摘 要：Diabetes mellitus (DM) is marked as global health care challenge with almost 10% of the United States population being diagnosed with DM. A sizeable percentage of patients are oblivious of their disease, in spite of easily accessibility knowledge about its early signs and symptoms and rapid diagnostic modalities. Critically ill patients with undiagnosed DM are likely to have an increased mortality as compared to intensive care unit (ICU) patients with diagnosed DM. DM may have adverse effect on ICU patients causing organ failure and complications. Early Screening of patients at the risk of developing disease may prevent long term complications. Early screening and management may be beneficial as controlled DM patients have similar morbidity as non DM patients in ICU. An intense glycaemic and blood pressure control improves retinopathy and albuminuria, but may not affect the macrovascular outcomes.
维普期刊数据库